Advertisement

Picture Consultech GmbH Secure Funding with RnD Grants v7 650x100px
Organisation › Details

Fluidigm Australia

Fluidigm (Nasdaq:FLDM) focuses on the most pressing needs in translational and clinical research, including cancer, immunology, and immunotherapy. Using proprietary CyTOF® and microfluidics technologies, we develop, manufacture, and market multi-omic solutions to drive meaningful insights in health and disease, identify biomarkers to inform decisions, and accelerate the development of more effective therapies. Our customers are leading academic, government, pharmaceutical, biotechnology, plant and animal research, and clinical laboratories worldwide. Together with them, we strive to increase the quality of life for all. *

 

Period Start 2016-06-12 existent
  Group Fluidigm (Group)
Product Industry analytical instrument
     
Region Region Sydney NSW
  Country Australia
  Street 50 Bridge Street
Level 27, AMP Centre
  City 2000 Sydney NSW
    Address record changed: 2020-12-02
     
Basic data Employees n. a.
     
    * Document for »About Section«: Fluidigm Corporation. (4/1/22). "Press Release: Fluidigm Stockholders Approve $250 Million Strategic Capital Infusion". South San Francisco, CA.
     
   
Record changed: 2023-07-10

Advertisement

Picture Berlin Partner Top News Healthtech Company Mika 650x200px

More documents for Fluidigm (Group)


To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com

Advertisement

Picture Berlin Partner BIO 2024 International Convention San Diego 650x300px




» top